SCYNEXIS, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SCYNEXIS, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $0.00.
- SCYNEXIS, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $17.00K, a 34.62% decline year-over-year.
- SCYNEXIS, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-12-31 was $0.00.
- SCYNEXIS, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $25.00K, a 19.35% decline year-over-year.
- SCYNEXIS, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $51.00K, a 8.93% decline from fiscal 2024.
- SCYNEXIS, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $56.00K, a 33.33% increase from fiscal 2023.
- SCYNEXIS, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $42.00K, a 133.33% increase from fiscal 2022.
- SCYNEXIS, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $18.00K, a 18.18% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $42.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $17.00K 10-Q · filed 2026-05-11 | $42.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $51.00K 10-K · filed 2026-03-04 |
| 2025-09-30 | $25.00K 10-Q · filed 2025-11-05 | $51.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $57.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $26.00K 10-Q · filed 2026-05-11 | $57.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $56.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | $31.00K 10-Q · filed 2025-11-05 | $57.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $64.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $26.00K 10-Q · filed 2025-05-15 | $64.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $42.00K 10-K · filed 2025-03-12 |
| 2023-09-30 | $38.00K 10-Q · filed 2024-11-06 | $42.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $12.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $4.00K 10-Q · filed 2024-05-08 | $12.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $18.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $8.00K 10-Q · filed 2023-11-13 | $18.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $23.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $10.00K 10-Q · filed 2023-05-10 | $26.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $22.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $13.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | |
| 2021-03-31 | $6.00K 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $28.00K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $9.00K 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $18.00K 10-Q · filed 2021-05-17 | $36.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $37.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | $17.00K 10-Q · filed 2020-11-06 | $38.00K derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $42.00K derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $20.00K 10-Q · filed 2020-05-11 | $41.00K derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $39.00K 10-K · filed 2020-03-11 |
| 2018-09-30 | $21.00K 10-Q · filed 2019-11-12 | $40.00K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $37.00K derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $20.00K 10-Q · filed 2019-05-08 | $38.00K derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $35.00K 10-K · filed 2019-03-14 |
| 2017-09-30 | $18.00K 10-Q · filed 2018-11-13 | $34.00K derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $32.00K derived: sum of 4 quarters · filed 2018-03-13 |
| 2017-03-31 | $17.00K 10-Q · filed 2017-05-08 | $31.00K derived: sum of 4 quarters · filed 2018-03-13 |
| 2016-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $19.00K 10-K · filed 2018-03-13 |
| 2016-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | |
| 2016-03-31 | $5.00K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $106.00K 10-K · filed 2017-03-13 | |
| 2014-12-31 | $68.00K 10-K · filed 2017-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |